Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
SANA | US
-0.13
-2.49%
Healthcare
Biotechnology
31/03/2024
05/07/2024
5.09
5.21
5.22
4.93
Sana Biotechnology Inc. a biotechnology company focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs including oncology diabetes central nervous system disorders cardiovascular diseases genetic disorders and others. Its product candidates include SG299 and SG242 that targets CD19+ cancer cells in patients with non-Hodgkin Lymphoma (NHL) chronic lymphocytic leukemia (CLL) and acute lymphoblastic leukemia (ALL); SG221 and SG239 for the treatment of multiple myeloma; and SG233 a CD22 CAR for the treatment of NHL CLL and ALL. It also develops SG418 for sickle cell disease and beta-thalassemia; SC291 a CD19 allogeneic T cell therapy; SC255 a B cell maturation antigen directed allogeneic CAR T for multiple myeloma; SC45 the PSC-derived pancreatic islet cells for type I diabetes mellitus; and SC379 for secondary progressive multiple sclerosis Pelizaeus-Merzbacher disease Huntington's disease and other astrocytic diseases. The company was formerly known as FD Therapeutics Inc. and changed its name to Sana Biotechnology Inc. in September 2018. The company was incorporated in 2018 and is based in Seattle Washington.
View LessLow Debt to Asset (< 0.2)
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
High Short percentage (> 15%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
44.0%1 month
73.8%3 months
80.4%6 months
107.1%-
-
6.86
0.28
0.16
-6.97
-
-
-329.69M
1.13B
1.13B
-
-
-
-
-76.83
15.79
22.98
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.80
Range1M
2.96
Range3M
5.57
Rel. volume
0.47
Price X volume
5.07M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Ardelyx Inc | ARDX | Biotechnology | 5.29 | 1.24B | -0.56% | n/a | 69.54% |
ARCUTIS BIOTHERAPEUTICS INC. | ARQT | Biotechnology | 10.49 | 1.21B | 9.27% | n/a | 91.91% |
immatics biotechnologies GmbH | IMTX | Biotechnology | 11.74 | 1.21B | -0.68% | n/a | 8.13% |
Day One Biopharmaceuticals Inc. Common Stock | DAWN | Biotechnology | 13.71 | 1.20B | 1.56% | n/a | 0.10% |
NRIX | NRIX | Biotechnology | 19.47 | 1.19B | 0.31% | n/a | 17.28% |
IRON | IRON | Biotechnology | 46.62 | 1.15B | 4.93% | n/a | 0.60% |
4D Molecular Therapeutics Inc | FDMT | Biotechnology | 21.15 | 1.09B | 1.44% | n/a | 2.36% |
Prothena Corporation plc | PRTA | Biotechnology | 20.26 | 1.09B | 0.95% | n/a | 2.49% |
Tarsus Pharmaceuticals Inc | TARS | Biotechnology | 27.88 | 1.05B | -3.63% | n/a | 11.09% |
Calliditas Therapeutics AB | CALT | Biotechnology | 39.19 | 1.05B | -0.10% | n/a | 292.45% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Pitney Bowes Inc | PBI | Building Products & Equipment | 6.36 | 1.14B | 1.60% | n/a | -628.58% |
Camping World Holdings Inc | CWH | Recreational Vehicles | 17.73 | 799.13M | -2.42% | n/a | 4070.84% |
Malibu Boats Inc | MBUU | Recreational Vehicles | 32.65 | 667.35M | -2.74% | n/a | 4.21% |
Ennis Inc | EBF | Building Products & Equipment | 21.25 | 552.16M | -0.75% | 13.68 | 1.15% |
ACCO Brands Corporation | ACCO | Building Products & Equipment | 4.48 | 428.47M | -2.40% | n/a | 138.85% |
ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 25.77 | 412.92M | -1.68% | n/a | 322.60% |
Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 11.74 | 369.15M | -2.49% | 14.12 | 86.68% |
Marine Products Corporation | MPX | Recreational Vehicles | 9.36 | 324.63M | -2.40% | 10.10 | 0.00% |
Latham Group Inc. | SWIM | Building Products & Equipment | 2.74 | 316.67M | -3.52% | 75.75 | 80.81% |
MCBC Holdings Inc | MCFT | Recreational Vehicles | 17.55 | 298.02M | -0.34% | 8.24 | 25.57% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -6.97 | -2.43 | Cheaper |
Ent. to Revenue | - | 4,101.76 | - |
PE Ratio | - | 41.26 | - |
Price to Book | 6.86 | 22.34 | Cheaper |
Dividend Yield | - | 2.39 | - |
Std. Deviation (3M) | 80.44 | 76.52 | Par |
Debt to Equity | 0.28 | 0.51 | Cheaper |
Debt to Assets | 0.16 | 0.24 | Cheaper |
Market Cap | 1.13B | 3.77B | Emerging |